ascender09
Iron
- Joined
- Aug 27, 2023
- Posts
- 76
- Reputation
- 36
Firstly, I will explain how both drugs work. They both agonise the Wnt pathway which is a potent activator of osteoblast activity. Way 316606 acts through binding to sFRP-1 proteins, preventing them from binding to Wnt ligands. This drvg has increasingly gained attention, not only for its potential effect of osteogenesis, but also for its hair growth effects. Similarly, WAY 262611 inhibits DKK-1, another extracellular Wnt antagonist, by binding to it, preventing it from binding to LRP5/6. Thus, both compounds target the same pathway to induce enhanced bone growth through inhibiting two different antagonists of the pathway.
will now move on to both In addition to this, WAY compounds pharmacological profiles. Using the EC50 metric used to show concentration of the drvg required to effect halfway between the baseline andmaximum. They both higher, although this is a have very similar potency, a topic I would like to go a negligible difference deeper into
between them, with 262611 being 0.63 pM, whilst 316606 is 0.65 pM.
In fact, these similar values could lead one to believe that 262611 is the clear choice between the two, because of the nature of its binding to DKK1, a far more prevelant antagonist within the plasma membrane than the sFRP1 proteins.
In addition to this, WAY 262611 was specifically engineered and modified to have a higher oral availability. However, this is not all there is to this debate, for I have reason to believe that the ROl of WAY 316606 could be higher, although this is a topic I would like to go deeper into
That being said, there are some significant drawbacks to 262611 and positives of 3616606 which further opens a debate as to which is better for
Periosteal expansion
Longitudinal growth
A drawback is that 262611s price is 2-3x that of standard chem supply 316606, due to poor stocking and lacking mass production pipelines.
Finally It is a common misconception that 316606 is largely nọt orally bioavailable. This is not the Case. It is a matter of reconstitution. By using a SEDDS based solution with LGT oils (corn, olive; sesame), an effective emulsifier, such as Tween 80, a macrogol like PEG300, or DMSO to fist dissolve the raw powder.
to reconstitute 316606 powder, its availability goes from 0 to a much more considerable value, anywhere between 30-80%, given that it is taken prior to phase separation (shoutout gavin). I hope this was informative dm for questions
will now move on to both In addition to this, WAY compounds pharmacological profiles. Using the EC50 metric used to show concentration of the drvg required to effect halfway between the baseline andmaximum. They both higher, although this is a have very similar potency, a topic I would like to go a negligible difference deeper into
between them, with 262611 being 0.63 pM, whilst 316606 is 0.65 pM.
In fact, these similar values could lead one to believe that 262611 is the clear choice between the two, because of the nature of its binding to DKK1, a far more prevelant antagonist within the plasma membrane than the sFRP1 proteins.
In addition to this, WAY 262611 was specifically engineered and modified to have a higher oral availability. However, this is not all there is to this debate, for I have reason to believe that the ROl of WAY 316606 could be higher, although this is a topic I would like to go deeper into
That being said, there are some significant drawbacks to 262611 and positives of 3616606 which further opens a debate as to which is better for
Periosteal expansion
Longitudinal growth
A drawback is that 262611s price is 2-3x that of standard chem supply 316606, due to poor stocking and lacking mass production pipelines.
Finally It is a common misconception that 316606 is largely nọt orally bioavailable. This is not the Case. It is a matter of reconstitution. By using a SEDDS based solution with LGT oils (corn, olive; sesame), an effective emulsifier, such as Tween 80, a macrogol like PEG300, or DMSO to fist dissolve the raw powder.
to reconstitute 316606 powder, its availability goes from 0 to a much more considerable value, anywhere between 30-80%, given that it is taken prior to phase separation (shoutout gavin). I hope this was informative dm for questions
